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Aim To describe and interpret lung cancer incidence and 
mortality trends in Croatia between 1988 and 2008.
Methods Incidence data on lung cancer for the period 
1988-2008 were obtained from the Croatian National Can-
cer Registry, while mortality data were obtained from the 
World Health Organization mortality database. Population 
estimates for Croatia were obtained from the Population 
Division of the Department of Economic and Social Affairs 
of the United Nations. We also calculated and analyzed 
age-standardized  incidence  and  mortality  rates.  To  de-
scribe time incidence and mortality trends, we used join-
point regression analysis.
Results Lung cancer incidence and mortality rates in men 
decreased significantly in all age groups younger than 70 
years. Age-standardized incidence rates in men decreased 
significantly by -1.3% annually. Joinpoint analysis of mortal-
ity in men identified three trends, and average annual per-
cent change (AAPC) decreased significantly by -1.1%. Lung 
cancer incidence and mortality rates in women increased 
significantly in all age groups older than 40 years and de-
creased in younger women (30-39- years). Age-standard-
ized incidence rates increased significantly by 1.7% annu-
ally. Joinpoint analysis of age-standardized mortality rates 
in women identified two trends, and AAPC increased sig-
nificantly by 1.9%.
Conclusion Despite the overall decreasing trend, Croa-
tia is still among the European countries with the highest 
male lung cancer incidence and mortality. Although the 
incidence trend in women is increasing, their age stan-
dardized incidence rates are still 5-fold lower than in men. 
These trends follow the observed decrease and increase in 
the prevalence of male and female smokers, respectively. 
These findings indicate the need for further introduction 
of  smoking  prevention  and  cessation  policies  targeting 
younger population, particularly women.
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Lung cancer is the most common malignancy worldwide, 
accounting for one fifth of all cancer-related deaths (1). 
There are different trends of lung cancer incidence and 
mortality throughout Europe, mostly reflecting different 
phases  of  smoking  epidemic  in  individual  countries.  In 
many European countries, the rates in men have recent-
ly decreased or stabilized, while the rates in women in-
creased (2-4). Because the majority of lung cancer deaths 
are attributed to tobacco smoking, any decline or decel-
eration in the lung cancer death rates could be attributed 
to the past antismoking interventions (5,6). Early indicators 
of progress in tobacco-smoking control are lung cancer 
trends in young adults (6).
About 90% of lung cancers in men and 83% in women are 
caused by smoking (7). The risk of developing lung can-
cer is affected by the level of consumption and duration 
of smoking (8), as well as the level of exposure to environ-
mental tobacco smoke (9). The second most important 
cause of lung cancer is radon, which was estimated to 
be responsible for 9% of lung cancer deaths in European 
countries (10). Other risk factors include exposure to as-
bestos (11), silica (12), nitrogen oxides (13), radiation to the 
chest as part of the treatment of malignant diseases (14-
16), and scarring on the lungs due to tuberculosis or recur-
rent pneumonia (17).
Currently in Croatia, lung cancer is the most common can-
cer in men and the fifth most common cancer in women, 
accounting for more than 2000 and 600 deaths per year, 
respectively (18,19). The aim of this study was to provide an 
overview of the temporal trends of lung cancer incidence 
and mortality in Croatia for the period 1988-2008.
MATeriAlS And MeThodS
data sources
Incidence data for the period 1988-2008 were obtained 
from the Croatian National Cancer Registry. The Registry, 
founded in 1959, covers the whole Croatian population 
(approximately  4.4  million  persons)  and  relies  on  man-
datory cancer notifications from primary and secondary 
health care sources and death certificates from the Croa-
tian Bureau of Statistics. The Registry has contributed data 
to the last three volumes of the Cancer Incidence in Five 
Continents series (20-22). In addition to incidence data, 
these publications report respective indices of data qual-
ity (proportion of morphologically verified cases, pro-
portion of cases registered from death certificates 
only, and mortality to incidence ratio) (20-22). Lung cancer 
was defined as ICD-10 codes C33 and C34 and ICD-9 code 
162. The number of lung cancer deaths was obtained from 
the World Health Organization (WHO) mortality database 
(19). Population estimates from Population Division of the 
Department of Economic and Social Affairs of the United 
Nations were used for calculating all incidence and mortal-
ity rates (23).
Statistical analysis
Age-standardized rates of cancer incidence in Croatia and 
truncated age-standardized rates (for ages 30-64) were cal-
culated by the direct standardization method, using the 
world standard population as a reference (24). To describe 
incidence and mortality time trends, we carried out join-
point regression analysis using the software Joinpoint Re-
gression Program, Version 3.5.2, October 2011. The analysis 
included logarithmic transformation of the rates, standard 
error, maximum number of five joinpoints, and minimum 
of four years between two joinpoints. All other program 
parameters were set to default values. The aim of the ap-
proach is to identify possible joinpoints where a significant 
change in the trend occurs. The method identifies join-
points based on regression models with 0-5 joinpoints. The 
final model selected was the most parsimonious of these, 
with the estimated annual percent change (EAPC) based 
on the trend within each segment (25). To quantify the 
trend over the whole period, the average annual percent 
change (AAPC) was calculated. The AAPC is computed as 
a geometric weighted average of the EAPC trend analy-
sis, with the weights equal to the lengths of each segment 
Figure 1. Joinpoint analyses of incidence (rhombs) and mortality (tri-
angles) for lung cancer in Croatian men, 1988-2008. ASr (W) – age stan-
dardized rate per 100 000 (using world standard population).95 Janković et al: Lung cancer epidemiology in Croatia
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during the pre-specified fixed interval. If an AAPC lies en-
tirely within a single joinpoint segment, the AAPC is equal 
to the EAPC for that segment. In these cases we reported 
the EAPCs (26).
In describing trends, the terms “significant increase” or “sig-
nificant decrease” signify that the slope of the trend was 
statistically significant (P < 0.05). For non-statistically signifi-
cant trends (P > 0.05), we used the terms “stable” (for EAPC 
between -0.5% and 0.5%), “non-statistically significant in-
crease” (for EAPC>0.5%), and “non-statistically significant 
decrease” (for EAPC<-0.5%). All statistical tests were two 
sided.
reSulTS
Men
The number of new lung cancer cases in men remained 
stable (Table 1). Crude incidence rates did not change and 
age-standardized rates (ASR) declined (Figure 1). Lung can-
cer age-standardized incidence rates in men decreased by 
one fifth, from 75.1/100 000 in the first five years (1988-1992) 
to 59.6/100 000 in the last five years (2004-2008). Mortality 
age-standardized rates in men changed from 66.5/100 000 
in the first five years (1988-1992) to 57.6/100 000 in the last 
five years (2004-2008), with an overall percent change of 
-13.4%. Joinpoint analysis (Table 2) showed a significant 
decrease in the incidence, with EAPC of -1.3% (95% confi-
dence interval [CI], -1.7% to -0.9%). For mortality, joinpoint 
analysis  (Table  3)  identified  three  trends.  From  1988  to 
1995, mortality significantly decreased, with EAPC of -2.6% 
(95% CI, -3.4% to -1.8%). From 1998 onwards, there was a 
non-significant increase of 2.1% (95% CI, -3.9% to 8.5%) fol-
lowed by another decreasing trend of -0.9% (95% CI, -1.3% 
to -0.4%). AAPC was -1.1% (95% CI, -1.9% to -0.2%). Analysis 
by ten-year age groups revealed that both incidence and 
mortality rates decreased significantly for all age groups 
<70 years old during the study period (Tables 2 and 3).
Women
In women, there was an increase in the number of cases 
and ASRs (Figure 2). Age-standardized incidence rates in-
creased by 26.5%, from 9.8/100 000 in the first five-years 
(1988-1992) to 12.4/100 000 in the last five-years (2004-
2008).  Mortality  age-standardized  rates  increased  by 
35.3%, from 8.5/100 000 in the first five years (1988-1992) 
to  12.5/100 000  in  the  last  five  years  (2004-2008).  Join-
point analysis showed a significantly increasing trend of 
TAble 1. lung cancer incidence and mortality in Croatia in 
the period 1988-2008. number of cases, crude rate, and age 
standardized rate per 100 000
incidence Mortality
Year n crude rate ASr* n crude rate ASr
Men:
1988 2115   97.4 77.3 1866   85.9 68.9
1989 2149   98.7 76.5 1848   84.9 67.0
1990 2307 105.6 80.7 1944   89.0 68.4
1991 2074   94.3 72.0 1900   86.4 66.0
1992 2051   92.5 69.0 1843   83.2 62.2
1993 2236 100.1 72.2 1880   84.2 61.2
1994 2080   92.6 65.2 1893   84.3 59.7
1995 2142   95.2 65.9 1848   82.1 57.1
1996 2343 104.4 71.0 1973   87.9 59.7
1997 2354 105.7 70.7 2050   92.0 61.4
1998 2167   98.2 64.4 2095   94.9 62.2
1999 2394 109.5 71.0 2070   94.7 60.9
2000 2457 113.2 71.7 2000   92.2 58.3
2001 2418 112.0 70.0 2161 100.1 62.1
2002 2351 109.3 67.0 2102   97.7 59.6
2003 2219 103.4 62.5 2110   98.3 59.1
2004 2152 100.5 59.5 2123   99.1 58.6
2005 2346 109.7 64.7 2086   97.6 57.2
2006 2181 102.2 60.2 2145 100.5 58.5
2007 2217 104.1 59.7 2170 101.9 57.8
2008 2024   95.2 53.9 2139 100.6 56.0
Women:
1988   342   14.8   9.0   307   13.3   8.0
1989   383   16.5   9.7   347   15.0   8.6
1990   441   18.9 11.3   341   14.6   8.5
1991   400   17.0 10.0   350   14.9   8.8
1992   386   16.3   9.2   367   15.5   8.6
1993   389   16.2   9.0   319   13.3   7.3
1994   408   16.9   9.4   346   14.3   8.0
1995   410   17.0   9.1   342   14.1   7.6
1996   507   21.0 11.1   417   17.3   9.0
1997   480   20.0 10.3   401   16.7   8.5
1998   439   18.5   9.3   474   20.0   9.9
1999   525   22.3 11.2   425   18.1   8.8
2000   589   25.2 12.9   478   20.5 10.4
2001   542   23.3 11.7   455   19.6   9.6
2002   590   25.5 12.8   496   21.4 10.3
2003   555   24.0 11.8   530   22.9 10.9
2004   586   25.4 12.0   512   22.2 10.9
2005   654   28.4 13.5   554   24.1 11.0
2006   664   28.9 14.3   572   24.9 11.7
2007   569   24.8 11.7   583   25.4 11.8
2008   514   22.4 10.4   611   26.7 12.3
*ASr – age standardized rate (using world standard population).CANCER EPIDEMIOLOGY 96 Croat Med J. 2012;53:93-9
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incidence, with EAPC of 1.7% (95% CI, 0.8% to 2.5%) (Table 
2). Joinpoint analysis of mortality (Table 3) identified one 
joinpoint in 1994. The first trend showed non-significant 
decrease, with EAPC of -1.0% (95% CI, -4.1% to 2.2%), fol-
lowed by a significant increase, with EAPC of 3.1% (95% 
CI, 2.3% to 3.9%) from 1994 to the end of the study pe-
riod. AAPC was 1.9% (95% CI, 0.9% to 2.9%) throughout 
the whole period. Analysis by ten-year age groups showed 
that both incidence and mortality increased significantly in 
all age groups older than 40 years and decreased in young-
er women (30-39 years). (Tables 2 and 3)
diSCuSSion
This study confirmed the findings that, despite the overall 
decreasing trend, Croatia is still among the European coun-
tries with the highest male lung cancer incidence and mor-
tality rate (27,28). With male ASR incidence and mortality of 
59.6 and 57.6/100 000 men, respectively, it is in the top five 
of the 40 analyzed European countries. Hungary has the 
highest estimated male ASR of mortality, of 73.5/100 000, 
while Cyprus has the lowest, of 21.3/100 000. Incidence 
and  mortality  in  women  are  considerably  lower.  Com-
pared to other European countries, Croatia has an interme-
diate incidence and mortality rate (12.4 and 12.5/100 000, 
respectively). Denmark has the highest mortality rate of 
30/100000 and Belarus the lowest – 3.7/100 000 (28).
More  than  a  quarter  of  all  adult  inhabitants  of  Croatia 
are every-day smokers (29). A survey conducted in 1972 
TAble 2. Joinpoint analysis of age-specific and age-standardized rates of lung cancer incidence in Croatia (1988-2008)
Trend 1 Trend 2 Trend 3
Age (years) years eAPC years eAPC years eAPC AAPC (1988-2008)
Men:
30-39 1988-2008 - 6.3† -6.3†
40-49 1988-2000     0.9 2000-2008 - 5.5† -1.7†
50-59 1988-1995 - 4.7† 1995-2008 - 0.6 -2.0†
60-69 1988-2001 - 0.9† 2001-2008 - 3.8† -2.0†
70-79 1988-1995 - 0.6 1995-2001   3.4 2001-2008 - 3.4* -0.4
>80 1988-2008     0.1   0.1
Age standardized:
overall 1988-2008 - 1.3† -1.3†
truncated (30-64) 1988-2008 - 2.0† -2.0†
Women:
30-39 1988-2008 - 3.2† -3.2
40-49 1988-2008     1.9 †  1.9†
50-59 1988-2008     3.5 †  3.5*
60-69 1988-2008     1.0 †  1.0†
70-79 1988-2004     2.7 † 2004-2008 - 6.8  0.7
>80 1988-2008     1.3 †  1.3†
Age standardized
overall 1988-2008     1.7 †  1.7†
truncated (30-64) 1988-2008     2.2 †  2.2†
*eAPC – estimated annual percent change; AAPC – average annual percent change.
†Statistically significant trend.
Figure 2. Joinpoint analyses of incidence (rhombs) and mortality (tri-
angles) for lung cancer in Croatian women, 1988-2008. ASr (W) – age 
standardized rate per 100 000 (using world standard population).97 Janković et al: Lung cancer epidemiology in Croatia
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showed a prevalence of daily cigarette smoking of 56.9% 
in men and 10.1% in women. In the period between 1972 
and 1997, the prevalence decreased among men and in-
creased among women. During the last decade, there has 
been a reduction in the frequency of smokers of both sex-
es (29,30). Our results show that lung cancer incidence and 
mortality rates in men have been constantly decreasing in 
most of the age groups. This trend is in agreement with 
the decrease in the prevalence of male smokers observed 
during the same period (29). On the other hand, women 
showed an increasing incidence trend, although their age 
standardized incidence rates are still five times lower than 
those of men. This increasing incidence trend follows the 
increase in the prevalence of female smokers (29) and re-
flects a lung cancer epidemic in women. Still, though not 
significant, we observed a stabilization and beginning of a 
decreasing trend in younger women (30-39 years). Togeth-
er with the initial reduction in the frequency of smokers 
among women during the last decade (30), this might be 
an early indicator that lung cancer incidence and mortal-
ity in women will reach a plateau or start declining in the 
future. The trends in Croatia are similar to those in most Eu-
ropean countries. The mortality trends in men are largely 
encouraging, since there are general declines in most Eu-
ropean countries, particularly during the last two decades, 
while there are still increases in parts of Southern (Portu-
gal and the Republic of Macedonia) and Eastern Europe 
(Bulgaria,  Romania,  and  Moldova)  (27).  Among  women, 
mortality rates have reached a plateau or are beginning to 
decline in a number of Eastern European countries (Hun-
gary, Poland, and the Czech Republic), and in Northern Eu-
rope (Denmark, Iceland, and the United Kingdom), which 
reflects recent changes in smoking habits. The trends in 
Western Europe (France and the Netherlands) and South-
ern Europe (Spain) are increasing (27).
Croatia still bears a major smoking-related health burden. 
Some of the most obvious barriers to implementing suc-
cessful  smoking  prevention  program  initiatives  include 
very limited resources, recent transnational tobacco indus-
try’s interest in the Croatian market, and the social accept-
ability  of  smoking.  By  ratifying  the  Framework  Conven-
tion for Tobacco Control, Croatia did integrate European 
tobacco bans, but smoking is still allowed in most of the 
bars and cafes (31). Because of a large number of older 
Croatians who have been smoking for decades, the rise 
in the number of tobacco-related deaths is expected 
to continue (31). Such trends encourage the imple-
TAble 3. Joinpoint analysis of age-specific and age-standardized rates of lung cancer mortality in Croatia (1988-2008)
Trend 1 Trend 2 Trend 3
Age (years) years eAPC Years eAPC years eAPC AAPC (1988-2008)
Men:
30-39 1988-2008 -8.7† -8.7†
40-49 1988-2000  0.2 2000-2008 -4.3† -1.6
50-59 1988-2000 -3.2† 2000-2008  1.2 -1.5†
60-69 1988-1993 -2.8† 1993-1999  0.8 1999-2008 -2.2† -1.5†
70-79 1988-1995 -1.5 1995-2002  3.1† 2002-2008 -0.4 0.4
>80 1988-1995 -4.8 1995-2008  3.3† 0.4
Age standardized:
overall 1988-1995 -2.6† 1995-1998  2.1 1998-2008 -0.9† -1.1†
truncated (30-64) 1988-2008 -1.8† -1.8†
Women:
30-39 1988-2008 -1.2 -1.2
40-49 1988-2008  2.9† 2.9†
50-59 1988-2008  2.7† 2.7†
60-69 1988-2008  2.1† 2.1†
70-79 1988-2008  2.0† 2.0†
>80 1988-2008  2.2† 2.2†
Age standardized:
overall 1988-1994 -1.0 1994-2008  3.1† 1.9†
truncated (30-64) 1988-2008  2.7† 2.7†
*eAPC – estimated annual percent change; AAPC – average annual percent change.
†Statistically significant trend.CANCER EPIDEMIOLOGY 98 Croat Med J. 2012;53:93-9
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mentation of smoking prevention and cessation policies, 
particularly those targeting younger population, especially 
women.
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